Home > Insider Trading > Filing (0001209191-20-016684)

Filing Details

Accession Number:: 0001209191-20-016684
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-05 17:21:55
Reporting Period:: 2020-03-03

Accepted Time:: 2020-03-05 17:21:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510487	Principia Biopharma Inc.	PRNB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1435618	Martin Babler	C/O Principia Biopharma Inc. 220 E. Grand Avenue South San Francisco CA 94080	President, Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-02-10	1,159	$0.00	0	No	5	G	Direct
Common Stock	Acquisiton	2020-02-10	1,159	$0.00	18,355	No	5	G	Indirect	See footnote
Common Stock	Disposition	2020-03-03	2,085	$62.45	52,094	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-03-03	7,183	$63.24	44,911	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-03-03	5,432	$64.10	39,479	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-03-03	300	$64.83	39,179	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2020-03-05	200,000	$0.00	200,000	$67.31

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
200,000		2030-03-04	No	4	A	Direct

Footnotes

Shares were gifted to three accounts held in trust for each of Martin Babler's minor children.
Shares indirectly held by Martin Babler, as custodian for his minor children under California Uniform Transfer to Minors Act, of which the Reporting Person is a custodian and may be deemed to share voting and dispositive power over these shares.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Represents the weighted average sales price per share. The shares sold at prices ranging from $61.74 to $62.735 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Shares indirectly held by Babler Trust Agreement Dated October 25, 2006, of which the Reporting Person is a trustee and may be deemed to share voting and dispositive power over these shares.
Represents the weighted average sales price per share. The shares sold at prices ranging from $62.74 to $63.725 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Represents the weighted average sales price per share. The shares sold at prices ranging from $63.75 to $64.695 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Represents the weighted average sales price per share. The shares sold at prices ranging from $64.78 to $64.90 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The stock option vests and becomes exercisable as to 25% of the shares subject to the option on March 5, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.